Published in Antibiot Med Biotekhnol on October 01, 1987
Electric field effect in atomically thin carbon films. Science (2004) 45.10
Two-dimensional gas of massless Dirac fermions in graphene. Nature (2005) 22.35
Nanofabricated media with negative permeability at visible frequencies. Nature (2005) 2.08
A dynamic model for in-vitro evaluation of antimicrobial action by simulation of the pharmacokinetic profiles of antibiotics. J Antimicrob Chemother (1989) 0.99
[Kinetics of the antimicrobial effect in a dynamic system: the microcalorimetric recording method and choice of parameters for characterizing kinetic curves]. Antibiot Med Biotekhnol (1985) 0.85
Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio. Antimicrob Agents Chemother (2000) 0.82
[Principles for analyzing the kinetic curves of the antimicrobial effect in dynamic systems simulating the pharmacokinetic profiles of antibiotics]. Antibiot Med Biotekhnol (1987) 0.81
Age dependence of erythromycin rectal bioavailability in children. Eur J Drug Metab Pharmacokinet (1991) 0.81
[Correlation between pharmacokinetic parameters of rifampicin and its biologically active metabolite as related to estimation of the relative bioavailability of the antibiotic]. Antibiot Khimioter (1996) 0.79
The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model. J Chemother (2011) 0.77
The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses. J Antimicrob Chemother (2001) 0.76
[Pharmacology of rifampicin]. Antibiotiki (1977) 0.76
Development of tolerance to nifedipine in patients with stable angina pectoris. Br J Clin Pharmacol (1990) 0.75
[A hearing disorder caused by a defect of the incus in children]. Vestn Otorinolaringol (1990) 0.75
[Penetration of oligo/polynucleotides and their polyalkylating derivatives into rat cells transformed by simian adenovirus DNA]. Mol Biol (Mosk) (1991) 0.75
[Results of determining the sensitivity of hypernephroid cancer to cytostatic agents in vitro and clinically]. Antibiotiki (1977) 0.75
[Optimal regime of intravenous administration of lincomycin in osteomyelitis]. Antibiotiki (1977) 0.75
[Pharmacokinetic validation of the nephrotoxic action of sisomycin. The relationship between nephrotoxicity and sisomycin concentration in the blood serum of rats]. Antibiotiki (1980) 0.75
[Effect of hydrocortisone on DNA synthesis in proliferating bone marrow cells]. Gematol Transfuziol (1984) 0.75
[Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)]. Antibiot Med Biotekhnol (1985) 0.75
[Cholesteatoma of the middle ear in childhood]. Vestn Otorinolaringol (1984) 0.75
[In vitro systems for the primary search for biologically active substances with carcinostatic action]. Eksp Onkol (1988) 0.75
[Pharmacokinetics of the new antitumor antibiotic reumycin in an experiment: the prediction of the human pharmacokinetic profiles]. Antibiot Med Biotekhnol (1985) 0.75
[Elaboration of the procedures for the pharmacokinetic interpretation of aminoglycoside nephrotoxicity: the experimental evaluation of the safety of repeated gentamycin administration]. Antibiotiki (1982) 0.75
[Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias]. Antibiotiki (1978) 0.75
[Aclacinomycin A: a new antitumor antibiotic]. Antibiotiki (1982) 0.75
[Research results and prospects in the field of experimental leukemia chemotherapy]. Probl Gematol Pereliv Krovi (1979) 0.75
[Results of a study of the pharmacokinetics of actinomycete RNAase in the bodies of white rats]. Antibiotiki (1977) 0.75
[Importance of determination of phases of mitotic cycle of cells in the treatment of acute leukemia (literature survey)]. Probl Gematol Pereliv Krovi (1976) 0.75
[Study of the distribution of C14-variamycin and C14-mitramycim after intravenous administration to mice]. Antibiotiki (1975) 0.75
[Dependence of the nephrotoxic effect of kanamycin on its concentration in the blood (an experimental study)]. Antibiotiki (1979) 0.75
[Pharmacokinetic basis of the nephrotoxic action of sisomycin. The pharmacokinetics of sisomycin in single and multiple administrations to rats]. Antibiotiki (1980) 0.75
[Catalytic properties of glucoamylase immobilized on the synthetic carbon material Sibunit]. Prikl Biokhim Mikrobiol (2007) 0.75
[A dynamic system for the in vitro study of the kinetics of the antimicrobial effect of antibiotics in pharmacokinetic changes in their concentration]. Antibiot Med Biotekhnol (1985) 0.75
[Use of a 2-part model of i pharmacokinetics of gentaniycin for maintaining a constant blood concentration in infusion intravenous (an experimental study)]. Antibiotiki (1975) 0.75
[Importance of dactinomycin in the current therapy of tumors]. Antibiot Med Biotekhnol (1985) 0.75
[Effect of cyclic adenosine-3', 5'-monophosphate on cells of experimental lympholeukemia L-5178]. Biull Eksp Biol Med (1976) 0.75
[Clinical pharmacokinetics and the optimal intravenous ampicillin administration regimen in children]. Antibiotiki (1981) 0.75
[Action of the antibiotic xanthothricin on Ehrlich ascites tumor cells]. Antibiotiki (1974) 0.75
[Myringoplasty in children]. Vestn Otorinolaringol (1978) 0.75
[Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora]. Antibiotiki (1977) 0.75
[Chondromyxoma of the ethmoid bone in a child]. Vestn Otorinolaringol (1982) 0.75
[Comparative characteristics of the methods for assessing aminoglycoside extraction with the artificial kidney tobramycin clearance and dialyzability]. Antibiotiki (1981) 0.75
[Relationship between nephrotixic effect of gentamicin and streptomycin and their blood levels in laboratory animals]. Antibiotiki (1976) 0.75
[Simulation of the pharmacokinetics of aminoglycosides in the kidneys: single and continuous intake of sisomicin and gentamicin by rats]. Antibiotiki (1983) 0.75
[Early diagnosis and prevention of hearing disorders in children]. Vestn Otorinolaringol (1976) 0.75
Relationship between the blood concentration of the drug and its cumulative effect: a pharmacokinetic analysis of the nephrotoxic action of gentamicin and streptomycin. Pharmazie (1978) 0.75
[Experimental and clinical data on the ototoxic properties of aminoglycoside antibiotics (aminocyclitols)]. Antibiotiki (1983) 0.75
[An analysis of the relationship between the serum concentration of streptomycin in experimental animals and its effect on the transmission of excitation at the neuromuscular synapses of skeletal musculature]. Antibiotiki (1974) 0.75
[Peridural anesthesia]. Sov Med (1972) 0.75
[Autoradiographic determination of the parameters of the mitotic cycle of tumors of human testis in tissue culture]. Biull Eksp Biol Med (1975) 0.75
[Experimental antimetastatic activity of aclarubicin]. Antibiot Khimioter (1988) 0.75
[Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents]. Antibiotiki (1977) 0.75
[Formation of colonies of P-388 leukemic cells in semisolid agar]. Biull Eksp Biol Med (1978) 0.75
[Effect of hexaphosphamide on the cellular cycle of mouse lympholeukemia L-1210]. Probl Gematol Pereliv Krovi (1976) 0.75
[New anti-leukemia anthracycline antibiotic aclarubicin]. Gematol Transfuziol (1989) 0.75
[Differential diagnosis and treatment of congenital external and middle ear anomalies in children]. Vestn Otorinolaringol (1981) 0.75
[Cephalexin pharmacokinetics]. Antibiotiki (1981) 0.75
[Effect of cyclosporin on tumor xenotransplantation under the renal capsule in mice]. Antibiot Khimioter (1989) 0.75
[The use of iodobromine water on patients with periodontitis at a health resort]. Stomatologiia (Mosk) (1990) 0.75
[Pharmacokinetic basis for using tobramycin and sisomicin in treating pyelonephritis of the transplanted kidney]. Antibiotiki (1983) 0.75
[Utilization of mathematical modeling of the pharmacokinetics for working out the optimal regimens of antibiotic administration in pediatric practice]. Vopr Okhr Materin Det (1975) 0.75
[Sinusitis and orbital complications in children]. Vestn Otorinolaringol (1977) 0.75
[Utilization of a mathematical model of the pharmacokinetics of streptomycin for maintaining its concentration in the blood at a given level under conditions of intravenous infusion]. Antibiotiki (1974) 0.75
[Pharmacokinetic interpretation of the myorelaxant effect of kanamycin]. Antibiotiki (1980) 0.75
[C14-variamycin content in normal and tumorous brain tissues of white rats]. Antibiotiki (1975) 0.75
[Effect of the antibiotic variamycin on the growth of a rabbit brain tumor]. Antibiot Med Biotekhnol (1986) 0.75
[Glucose isomerase activity in suspension of Arthrobacter nicotianae cells and adsorption immobilization of the microorganisms on inorganic carriers]. Prikl Biokhim Mikrobiol (2008) 0.75
[Antileukemic activity of carminomycin complexes with a high-polymer DNA]. Antibiotiki (1980) 0.75
[Mathematical models of pharmacokinetics in chemotherapy]. Pharmazie (1976) 0.75
[Pharmacokinetic prediction of the efficacy of using sisomicin in wound infections]. Antibiotiki (1983) 0.75
[Pharmacokinetics of sisomicin during hemosorption and hemodialysis]. Antibiot Med Biotekhnol (1985) 0.75
[Clinical pharmacokinetics of the antitumor antibiotic reumycin: an analysis of individual variability]. Antibiot Med Biotekhnol (1985) 0.75
[Use of a mathematical model of pharmacokinetics in the study of liver function in albino rats by the method of sulfobromophtalein test]. Lab Delo (1976) 0.75
[Development of a rational plan for the administration of anti-tumor preparations under experimental conditions]. Probl Gematol Pereliv Krovi (1969) 0.75
[Graphic method of assessing the maximum cumulative excretion of a drug]. Antibiotiki (1983) 0.75
[Pharmacokinetic validation of the antitumor efficacy of aclarubicin administered by various routes in CBF1 mice with Ca 755 carcinoma]. Eksp Onkol (1989) 0.75
[Sisomicin pharmacokinetics in rat tissues in single and long-term administration]. Antibiotiki (1981) 0.75
[Nerve-blocking properties of antibiotics]. Antibiotiki (1977) 0.75
[A new antianginal preparation: isosorbide-5-mononitrate]. Kardiologiia (1990) 0.75
[New antineoplastic antibiotics of the anthracycline group and the prospects of their clinical use]. Antibiot Khimioter (1988) 0.75
[Remote results of meatotympanoplasty in congenital developmental defects of the external and middle ear in children]. Vestn Otorinolaringol (1986) 0.75
[Chymotrypsin in the treatment of chronic catarrh and adhesive otitis in children]. Vestn Otorinolaringol (1970) 0.75
[Action of aureolic acid and dactinomycin group antibiotics on human brain tumors in culture]. Antibiotiki (1978) 0.75
Relationship between the neuromuscular blocking effect of gentamicin and streptomycin and their concentration in blood. Acta Biol Med Ger (1977) 0.75
[Decrease of sisomicin nephrotoxicity as affected by cephalothin: pharmacokinetic evaluation]. Antibiot Med Biotekhnol (1985) 0.75
[Comparative evaluation of different methods of administration of chymotrypsin in adhesive processes of the middle ear in children]. Vestn Otorinolaringol (1973) 0.75
[Pharmacokinetic analysis of the nephrotoxic effect of sisomycin]. Antibiotiki (1981) 0.75
[Antitumor antibiotics: unresolved problems and the prospects for further search]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Build up of a given concentration of tobramycin and sisomycin in the blood of young children by the intravenous infusion of the antibiotics according to a calculated regimen]. Antibiotiki (1982) 0.75
[Endaural surgery in children]. Vestn Otorinolaringol (1992) 0.75
[Surgical policy in chronic purulent otitis media in children]. Vestn Otorinolaringol (1999) 0.75
[Role of the individual sensitivity to various cytostatic agents in children with neuroblastomas]. Antibiotiki (1976) 0.75
[Comparative experimental antitumor activity of the antibiotics variamycin and mitramycin]. Antibiotiki (1978) 0.75
[Antitumor activity of fatty acid derivatives isolated from protozoa]. Antibiotiki (1977) 0.75
[Leukemogenesis and problems in seeking out experimental anti-leukemia drugs]. Probl Gematol Pereliv Krovi (1976) 0.75
[Comparative study of the relationship between the blood concentration of gentamicin and streptomycin and their muscle-relaxing activity]. Antibiotiki (1975) 0.75